Metabotropic actions of kainate receptors in the regulation of I sAHP and excitability in CA1 pyramidal cells

Advances in Experimental Medicine and Biology

Volumn 717, Issue , 2011, Pages 49-58

  Melyan, Zara ^a   Wheal, Howard V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENYLATE CYCLASE INHIBITOR; ALPHA AMINO 5 TERT BUTYL 3 HYDROXY 4 ISOXAZOLEPROPIONIC ACID; ATROPINE; CALPHOSTIN C; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; KAINIC ACID; KAINIC ACID RECEPTOR; MCPG; METABOTROPIC RECEPTOR ANTAGONIST; MITOGEN ACTIVATED PROTEIN KINASE; MSOP; N ETHYLMALEIMIDE; NALOXONE; NORADRENALIN; PERTUSSIS TOXIN; PICROTOXIN; PROTEIN KINASE C; SACLOFEN; UNCLASSIFIED DRUG;

AFTERHYPERPOLARIZATION; ARTICLE; CONCENTRATION RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; HIPPOCAMPAL CA1 REGION; HUMAN; INHIBITORY POSTSYNAPTIC POTENTIAL; NERVE CELL EXCITABILITY; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYNAPTIC INHIBITION; ANIMAL; METABOLISM; REVIEW; SYNAPSE;

ANIMALS; HUMANS; PYRAMIDAL CELLS; RECEPTORS, KAINIC ACID; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 79960894862     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9557-5_5     Document Type: Article

References (40)

1. Vignes M, Collingridge GL. The synaptic activation of kainate receptors. Nature 1997; 388:179-182. (Pubitemid 27297454)
2. Castillo PE, Malenka RC, Nicoll RA. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature 1997; 388:182-186. (Pubitemid 27297455)
3. Cossart R, Esclapez M, Hirsch JC, et al. GluR5 kainate receptor activation in interneurons increases tonic inhibition of pyramidal cells. Nat Neurosci 1998; 1:470-478.
4. Frerking M, Malenka RC, Nicoll RA. Synaptic activation of kainate receptors on hippocampal interneurons. Nat Neurosci 1998; 1:479-486.
5. Bureau I, Bischoff S, Heinemann SF, et al. Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice. J Neurosci 1999; 19:653-663. (Pubitemid 29036017)
6. Rodríguez-Moreno A, Lerma J. Kainate receptor modulation of GABA release involves a metabotropic function. Neuron 1998; 20:1211-1218. (Pubitemid 28293137)
7. Lancaster B, Adams PR. Calcium-dependent current generating the afterhyperpolarization of hippocampal neurons. J Neurophysiol 1986; 55:1268-1282. (Pubitemid 16068465)
8. Madison DV, Nicoll RA. Control of the repetitive discharge of rat CA1 pyramidal neurons in vitro. J Physiol 1984; 354:319-331. (Pubitemid 14066369)
9. Traub RD, Miles R, Jefferys JGR. Synaptic and intrinsic conductances shape picrotoxin-induced synchronized after-discharges in the guinea-pig hippocampal slice. J Physiol 1993; 461:525-547. (Pubitemid 23104404)
10. Nicoll RA. The coupling of neurotransmitter receptors to ion channels in the brain. Science 1988; 241:545-551.
11. Müller W, Petrozzino JJ, Griffith LC, et al. Specific involvement of Ca2+-calmodulin kinase II in cholinergic modulation of neuronal responsiveness. J Neurophysiol 1992; 68:2264-2269. (Pubitemid 23015525)
12. Madison DV, Nicoll RA. Actions of noradrenaline recorded intracellularly in rat hippocampal CA1 pyramidal neurons, in vitro. J Physiol 1986; 372:221-244.
13. Pedarzani P, Storm JF. PKA mediates the effects of monoamine transmitters on the Kcurrent underlying the slow spike frequency adaptation in hippocampal neurons. Neuron 1993; 11:1023-1035. (Pubitemid 24015277)
14. Ashwood TJ, Lancaster B, Wheal HV. Intracellular electrophysiology of CA1 pyramidal neurons in slices of the kainic acid lesioned hippocampus of the rat. Exp Brain Res 1986; 62:189-198. (Pubitemid 16162075)
15. Melyan Z, Wheal HV, Lancaster B. Metabotropic-mediated kainite receptor regulation of IsAHP and excitability in pyramidal cells. Neuron 2002; 34:107-114. (Pubitemid 34270702)
16. Melyan Z, Lancaster B, Wheal HV. Metabotropic regulation of intrinsic excitability by synaptic activation of kainate receptors. J Neurosci 2004; 24:4530-4534. (Pubitemid 38656608)
17. Debonnel G, Beauchesne L, de Montigny C. Domoic acid, the alleged "mussel toxin," might produce its neurotoxic effect through kainate receptor activation: an electrophysiological study in the dorsal hippocampus. Can J Physiol Pharmacol 1989; 67:29-33. (Pubitemid 19068108)
18. Wong LA, Mayer ML, Jane DE, et al. Willardiines differentiate agonist binding sites for kainate-versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons. J Neurosci 1994; 14:3881-3897.
19. Jane DE, Hoo K, Kamboj R, et al. Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes. J Med Chem 1997; 40:3645-3650. (Pubitemid 27465096)
20. Paternain AV, Morales M, Lerma J. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron 1995; 14:185-189.
21. Bleakman D, Ballyk BA, Schoepp DD, et al. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology 1996; 35:1689-1702. (Pubitemid 27090788)
22. Clarke VR, Ballyk BA, Hoo KH, et al. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 1997; 389:599-603. (Pubitemid 27446176)
23. Fisahn A, Contractor A, Traub RD, et al. Distinct roles for the kainate receptor subunits GluR5 and GluR6 in kainate-induced hippocampal gamma oscillations. J Neurosci 2004; 24:9658-9668. (Pubitemid 39441520)
24. Ruiz A, Sachidhanandam S, Utvik JK, et al. Distinct subunits in heteromeric kainate receptors mediate ionotropic and metabotropic function at hippocampal mossy fiber synapses. J Neurosci 2005; 25:11710-11718. (Pubitemid 43098463)
25. Min MY, Melyan Z, Kullmann DM. Synaptically released glutamate reduces gamma-aminobutyric acid (GABA)ergic inhibition in the hippocampus via kainate receptors. Proc Natl Acad Sci USA 1999; 96:9932-9937. (Pubitemid 29398835)
26. Heuss C, Scanziani M, Gahwiler BH, et al. G-protein-independent signaling mediated by metabotropic glutamate receptors. Nat Neurosci 1999; 2:1070-1077. (Pubitemid 30126364)
27. Frerking M, Schmitz D, Zhou Q, et al. Kainate receptors depress excitatory synaptic transmission at CA3-CA1 synapses in the hippocampus via a direct presynaptic action. J Neurosci 2001; 21:2958-2966. (Pubitemid 32323476)
28. Malenka RC, Madison DV, Andrade R, et al. Phorbol esters mimic some cholinergic actions in hippocampal pyramidal neurons. J Neurosci 1986; 6:475-480. (Pubitemid 16125041)
29. Pedarzani P, Storm JF. PKA mediates the effects of monoamine transmitters on the Kcurrent underlying the slow spike frequency adaptation in hippocampal neurons. Neuron 1993; 11:1023-1035. (Pubitemid 24015277)
30. Grabauskas G, Lancaster B, OConnor V, et al. Protein kinase signalling requirements for metabotropic action of kainate receptors in rat CA1 pyramidal neurones. J Physiol 2007; 579(2):363-373. (Pubitemid 46351755)
31. Katada T, Ui M. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc Natl Acad Sci USA 1982; 79:3129-3133.
32. Freissmuth M, Boehm S, Beindl W, et al. Suramin analogues as subtype-selective G protein inhibitors. Mol Pharmacol 1996; 49:602-611. (Pubitemid 26117644)
33. Chijiwa T, Mishima A, Hagiwara M, et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 1990; 265:5267-5272.
34. Dostmann WR, Taylor SS, Genieser HG, et al. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3,5cyclic phosphorothioates. J Biol Chem 1990; 251:10484-10491.
35. Holgate ST, Lewis RA, Austen KF. Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs. Proc Natl Acad Sci USA 1980; 77:6800-6804. (Pubitemid 11163488)
36. Roberson ED, English JD, Adams JP, et al. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J Neurosci 1999; 19:4337-4348. (Pubitemid 29241087)
37. English JD, Sweatt JD. Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation. J Biol Chem 1996; 271:24329-24332. (Pubitemid 26333160)
38. Coogan AN, OLeary DM, OConnor JJ. P42/44 MAP kinase inhibitor PD98059 attenuates multiple forms of synaptic plasticity in rat dentate gyrus in vitro. J Neurophysiol 1999; 81:103-110. (Pubitemid 29264158)
39. Winder DG, Martin KC, Muzzio IA, et al. ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by beta-adrenergic receptors. Neuron 1999; 24:715-726.
40. Lubin FD, Johnston LD, Sweatt JD, et al. Kainate mediates nuclear factor-kappa B activation in hippocampus via phosphatidylinositol-3 kinase and extracellular signal-related protein kinase. Neuroscience 2005; 133:969-981. (Pubitemid 40814605)